Glutathione suppresses cerebral infarct volume and cell death after ischemic injury: Involvement of FOXO3 inactivation and Bcl2 expression

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Song, Juhyun ^a   Park, Joohyun ^a   Oh, Yumi ^a   Lee, Jong Eun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; CELL DEATH; CELLS; CYTOLOGY; MOBILE SECURITY; PEPTIDES;

CEREBRAL INFARCTION; ISCHEMIA/REPERFUSION; MIDDLE CEREBRAL ARTERY OCCLUSIONS; PI3K/AKT PATHWAYS; PROTECTIVE FUNCTION; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; SIGNALING MECHANISMS;

CELL SIGNALING;

CLAUDIN 5; GLUTATHIONE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR FKHRL1; ANTIOXIDANT; FORKHEAD TRANSCRIPTION FACTOR; FOXO3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL SURVIVAL; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BLOOD BRAIN BARRIER; BRAIN; CELL DEATH; CELL HYPOXIA; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN ISCHEMIA; CELL DEATH; CELL HYPOXIA; CELL LINE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GLUTATHIONE; MALE; MICE; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84923875879     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/426069     Document Type: Article

References (76)

1. Y. Zhang, P. Zhang, X. Shen et al., "Early exercise protects the blood-brain barrier from ischemic brain injury via the regulation of MMP-9 and occludin in rats," International Journal of Molecular Sciences, vol. 14, no. 6, pp. 11096-11112, 2013.
2. A.W. Unterberg, J. Stover, B. Kress, and K. L. Kiening, "Edema and brain trauma," Neuroscience, vol. 129, no. 4, pp. 1021-1029, 2004.
3. J. M. Simard, T. A. Kent, M. Chen, K. V. Tarasov, and V. Gerzanich, "Brain oedema in focal ischaemia:molecular pathophysiology and theoretical implications," The Lancet Neurology, vol. 6, no. 3, pp. 258-268, 2007.
4. C. Loreto and E. Reggio, "Aquaporin and vascular diseases," Current Neuropharmacology, vol. 8, no. 2, pp. 105-111, 2010.
5. W. C. Risher, R. D. Andrew, and S. A. Kirov, "Real-time passive volume responses of astrocytes to acute osmotic and ischemic stress in cortical slices and in vivo revealed by two-photon microscopy," Glia, vol. 57, no. 2, pp. 207-221, 2009.
6. L. Hirt, B. Ternon, M. Price, N. Mastour, J. F. Brunet, and J. Badaut, "Protective role of early Aquaporin 4 induction against postischemic edema formation," Journal of Cerebral Blood Flow and Metabolism, vol. 29, no. 2, pp. 423-433, 2009.
7. D. Strbian, A. Durukan, M. Pitkonen et al., "The bloodbrain barrier is continuously open for several weeks following transient focal cerebral ischemia," Neuroscience, vol. 153, no. 1, pp. 175-181, 2008.
8. A. Sarkaki, M. Rafieirad, S. E. Hossini et al., "Improvement in memory and brain long-term potentiation deficits due to permanent hypoperfusion/ischemia by grape seed extract in rats," Iranian Journal of BasicMedical Sciences, vol. 16, no. 9, pp. 1004-1010, 2013.
9. E. Cadenas, "Mitochondrial free radical production and cell signaling,"Molecular Aspects ofMedicine, vol. 25, no. 1-2, pp. 17-26, 2004.
10. F. Q. Schafer and G. R. Buettner, "Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple," Free Radical Biology & Medicine, vol. 30, no. 11, pp. 1191-1212, 2001.
11. J. Cai and D. P. Jones, "Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss," Journal of Biological Chemistry, vol. 273, no. 19, pp. 11401-11404, 1998.
12. M. A. Ansari and S. W. Scheff, "Oxidative stress in the progression of Alzheimer disease in the frontal cortex," Journal of Neuropathology and Experimental Neurology, vol. 69, no. 2, pp. 155-167, 2010.
13. M. Merad-Boudia, A. Nicole, D. Santiard-Baron, C. Saillé, and I. Ceballos-Picot, "Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease," Biochemical Pharmacology, vol. 56, no. 5, pp. 645-655, 1998.
14. I. M. Cojocaru, M. Cojocaru, V. Sapira, and A. Ionescu, "Evaluation of oxidative stress in patients with acute ischemic stroke," Romanian Journal of Internal Medicine, vol. 51, no. 2, pp. 97-106, 2013.
15. K. van Leyen, H. Y. Kim, S. R. Lee, G. Jin, K. Arai, and E. H. Lo, "Baicalein and 12/15-lipoxygenase in the ischemic brain," Stroke, vol. 37, no. 12, pp. 3014-3018, 2006.
16. N. J. Abbott, A. A. K. Patabendige,D.E.M. Dolman, S. R. Yusof, and D. J. Begley, "Structure and function of the blood-brain barrier," Neurobiology of Disease, vol. 37, no. 1, pp. 13-25, 2010.
17. R. Jin, Z. Song, S. Yu et al., "Phosphatidylinositol-3-kinase gamma plays a central role in blood-brain barrier dysfunction in acute experimental stroke," Stroke, vol. 42, no. 7, pp. 2033-2044, 2011.
18. Z. Ahmed and W. H. Tang, "Pharmacologic strategies to target oxidative stress in heart failure," Current Heart Failure Reports, vol. 9, no. 1, pp. 14-22, 2012.
19. P. V. Usatyuk, S. Vepa, T. Watkins, D. He, N. L. Parinandi, and V. Natarajan, "Redox regulation of reactive oxygen speciesinduced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells," Antioxidants and Redox Signaling, vol. 5, no. 6, pp. 723-730, 2003.
20. M. Okouchi,N. Okayama, and T.Y. Aw, "Preservation of cellular glutathione status and mitochondrial membrane potential by N-acetylcysteine and insulin sensitizers prevent carbonyl stressinduced human brain endothelial cell apoptosis," Current Neurovascular Research, vol. 6, no. 4, pp. 267-278, 2009.
21. S. K. Biswas, D. E. Newby, I. Rahman, and I. L. Megson, "Depressed glutathione synthesis precedes oxidative stress and atherogenesis in Apo-E-/- mice," Biochemical and Biophysical Research Communications, vol. 338, no. 3, pp. 1368-1373, 2005.
22. K. Takahashi, R. Tatsunami, T. Oba, and Y. Tampo, "Buthionine sulfoximine promotes methylglyoxal-induced apoptotic cell death and oxidative stress in endothelial cells," Biological and Pharmaceutical Bulletin, vol. 33, no. 4, pp. 556-560, 2010.
23. K. Namba, Y. Takeda, K. Sunami, and M. Hirakawa, "Temporal profiles of the levels of endogenous antioxidants after fourvesselocclusion in rats," Journal ofNeurosurgicalAnesthesiology, vol. 13, no. 2, pp. 131-137, 2001.
24. E.-M. Park, J.-H. Choi, J.-S. Park, M.-Y. Han, and Y.-M. Park, "Measurement of glutathione oxidation and 8-hydroxy- 2'-deoxyguanosine accumulation in the gerbil hippocampus following global ischemia," Brain Research Protocols, vol. 6, no. 1-2, pp. 25-32, 2000.
25. Q. Xie, J. Chen, and Z. Yuan, "Post-translational regulation of FOXO," Acta Biochim Biophys Sin (Shanghai), vol. 44, no. 11, pp. 897-901, 2012.
26. R. S. Beard, R. J. Haines, K. Y. Wu et al., "Non-muscleMlck is required for beta-catenin- and FoxO1-dependent downregulation of Cldn5 in IL-1beta-mediated barrier dysfunction in brain endothelial cells," Journal of Cell Science, vol. 127, no. 8,pp. 1840-1853, 2014.
27. K. Fukunaga and N. Shioda, "Pathophysiological relevance of forkhead transcription factors in brain ischemia," Advances in ExperimentalMedicine and Biology, vol. 665, pp. 130-142, 2009.
28. W. Zhou, Q. Cao, Y. Peng et al., "FoxO4 inhibits NF-kappaB and protects mice against colonic injury and inflammation," Gastroenterology, vol. 137, no. 4, pp. 1403-1414, 2009.
29. S.-W. Hyun and Y.-S. Jung, "Hypoxia induces FoxO3a-mediated dysfunction of blood-brain barrier," Biochemical and Biophysical Research Communications, vol. 450, no. 4, pp. 1638-1642, 2014.
30. A. Sengupta, J. D. Molkentin, J.-H. Paik, R. A. DePinho, and K. E. Yutzey, "FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress," Journal of Biological Chemistry, vol. 286, no. 9, pp. 7468-7478, 2011.
31. M. Stahl, P. F. Dijkers, G. J. P. L. Kops et al., "The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2," Journal of Immunology, vol. 168, no. 10, pp. 5024-5031, 2002.
32. P. Storz, "Forkhead homeobox type O transcription factors in the responses to oxidative stress," Antioxidants and Redox Signaling, vol. 14, no. 4, pp. 593-605, 2011.
33. G. J. P. L. Kops, T. B. Dansen, P. E. Polderman et al., "Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress," Nature, vol. 419, no. 6904, pp. 316-321, 2002.
34. A. van der Horst and B. M. T. Burgering, "Stressing the role of FoxO proteins in lifespan and disease," Nature Reviews Molecular Cell Biology, vol. 8, no. 6, pp. 440-450, 2007.
35. A. Brunet, A. Bonni, M. J. Zigmond et al., "Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor," Cell, vol. 96, no. 6, pp. 857-868, 1999.
36. C. Skurk, Y. Izumiya, H. Maatz et al., "The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling," The Journal of Biological Chemistry, vol. 280, no. 21, pp. 20814-20823, 2005.
37. H.W. Chung, J. H. Lim, M. Y. Kimet al., "High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα-FoxO3a-PGC-1α pathway," Nephrology Dialysis Transplantation, vol. 27, no. 6, pp. 2213-2225, 2012.
38. K. Holm and O. Isacson, "Factors intrinsic to the neuron can induce and maintain its ability to promote axonal outgrowth: a role for BCL2?" Trends in Neurosciences, vol. 22, no. 6, pp. 269-273, 1999.
39. J. C. Reed, K. S. Doctor, and A. Godzik, "The domains of apoptosis: a genomics perspective," Science's STKE, vol. 2004, no. 239, article re9, 2004.
40. A. Selvamani and F. Sohrabji, "The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1," Journal of Neuroscience, vol. 30, no. 20, pp. 6852-6861, 2010.
41. R. J. Schauer, S. Kalmuk, A. L. Gerbes et al., "Intravenous administration of glutathione protects parechymal and nonparanchymal liver cells against reperfusion injury following rat liver transplantation,"World Journal of Gastroenterology, vol. 10, no. 6, pp. 864-870, 2004.
42. F. Papadopulos,M. Spinelli, S. Valente et al., "Common tasks in microscopic and ultrastructural image analysis using ImageJ," Ultrastructural Pathology, vol. 31, no. 6, pp. 401-407, 2007.
43. H.-J. Jung, Y.-H. Jeon, K. K. Bokara et al., "Agmatine promotes the migration of murine brain endothelial cells via multiple signaling pathways," Life Sciences, vol. 92, no. 1, pp. 42-50, 2013.
44. Z. Y. Mei, C. M. Chin, J. C. Yoon et al., "Agmatine inhibitsmatrix metalloproteinase-9 via endothelial nitric oxide synthase in cerebral endothelial cells," Neurological Research, vol. 29, no. 7, pp. 749-754, 2007.
45. J. A. Royall and H. Ischiropoulos, "Evaluation of 2',7'- dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells," Archives of Biochemistry and Biophysics, vol. 302, no. 2, pp. 348-355, 1993.
46. T. Mizui, H. Kinouchi, and P. H. Chan, "Depletion of brain glutathione by buthionine sulfoximine enhances cerebral ischemic injury in rats," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 262, no. 2, pp. H313-H317, 1992.
47. H. Shimizu, Y. Kiyohara, I. Kato et al., "Relationship between plasma glutathione levels and cardiovascular disease in a defined population: the Hisayama study," Stroke, vol. 35, no. 9, pp. 2072-2077, 2004.
48. P. J. Crack, J. M. Taylor, N. J. Flentjar et al., "Increased infarct size and exacerbated apoptosis in the glutathione peroxidase-1 (Gpx-1) knockout mouse brain in response to ischemia/reperfusion injury," Journal of Neurochemistry, vol. 78, no. 6, pp. 1389-1399, 2001.
49. N. Mitsios, J. Gaffney, J. Krupinski et al., "Expression of signaling molecules associated with apoptosis in human ischemic stroke tissue," Cell Biochemistry and Biophysics, vol. 47, no. 1, pp. 73-85, 2007.
50. B. T. Hawkins and T. P. Davis, "The blood-brain barrier/neurovascular unit in health and disease," Pharmacological Reviews, vol. 57, no. 2, pp. 173-185, 2005.
51. A.-C. Luissint, C. Federici, F. Guillonneau et al., "Guanine nucleotide-binding protein Galphai2: a new partner of claudin- 5 that regulates tight junction integrity in human brain endothelial cells," Journal of Cerebral BloodFlowandMetabolism, vol. 32, no. 5, pp. 860-873, 2012.
52. M. A. Petty and E. H. Lo, "Junctional complexes of the bloodbrain barrier: permeability changes in neuroinflammation," Progress in Neurobiology, vol. 68, no. 5, pp. 311-323, 2002.
53. C. M. Niessen, "Tight junctions/adherens junctions: basic structure and function," Journal of Investigative Dermatology, vol. 127, no. 11, pp. 2525-2532, 2007.
54. A. M. Romanic, R. F. White, A. J. Arleth, E. H. Ohlstein, and F. C. Barone, "Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size," Stroke, vol. 29, no. 5, pp. 1020-1030, 1998.
55. W.-Y. Liu, Z.-B. Wang, L.-C. Zhang, X. Wei, and L. Li, "Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances," CNS Neuroscience and Therapeutics, vol. 18, no. 8, pp. 609-615, 2012.
56. U. Dirnagl, C. Iadecola, and M. A. Moskowitz, "Pathobiology of ischaemic stroke: an integrated view," Trends in Neurosciences, vol. 22, no. 9, pp. 391-397, 1999.
57. M. B. Toledano, I. Kullik, F. Trinh, P. T. Baird, T. D. Schneider, and G. Storz, "Redox-dependent shift of OxyR-DNA contacts along an extended DNA-binding site: a mechanism for differential promoter selection," Cell, vol. 78, no. 5, pp. 897-909, 1994.
58. T. Furuyama, T. Nakazawa, I. Nakano, and N. Mori, "Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues," Biochemical Journal, vol. 349, no. 2, pp. 629-634, 2000.
59. J. Nakae, B. C. Park, and D. Accili, "Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a wortmannin-sensitive pathway," The Journal of Biological Chemistry, vol. 274, no. 23, pp. 15982-15985, 1999.
60. D. Accili and K. C. Arden, "FoxOs at the crossroads of cellular metabolism, differentiation, and transformation," Cell, vol. 117, no. 4, pp. 421-426, 2004.
61. X. Zhang, N. Tang, T. J. Hadden, and A. K. Rishi, "Akt, FoxO and regulation of apoptosis," Biochimica et Biophysica Acta- Molecular Cell Research, vol. 1813, no. 11, pp. 1978-1986, 2011.
62. D. R. Calnan and A. Brunet, "The FoxO code," Oncogene, vol. 27, no. 16, pp. 2276-2288, 2008.
63. O. Puig and J. Mattila, "Understanding forkhead box class o function: lessons from Drosophila melanogaster," Antioxidants and Redox Signaling, vol. 14, no. 4, pp. 635-647, 2011.
64. P. K. Vogt, H. Jiang, and M. Aoki, "Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins," Cell Cycle, vol. 4, no. 7, pp. 908-913, 2005.
65. F. Wang, Y.-Q. Wang,Q. Cao et al., "Hydrogen peroxide induced impairment of endothelial progenitor cell viability is mediated through a FoxO3a dependant mechanism," Microvascular Research, vol. 90, pp. 48-54, 2013.
66. A. H. H. Tseng, S.-S. Shieh, and D. L. Wang, "SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage," Free Radical Biology & Medicine, vol. 63, pp. 222-234, 2013.
67. N. R. Sundaresan, M. Gupta, G. Kim, S. B. Rajamohan, A. Isbatan, and M. P. Gupta, "Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice," Journal of Clinical Investigation, vol. 119, no. 9, pp. 2758-2771, 2009.
68. K. M. Jacobs, J.D. Pennington, K. S. Bisht et al., "SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression," International Journal of Biological Sciences, vol. 4, no. 5, pp. 291-299, 2008.
69. T. Kojima, T. Norose, K. Tsuchiya, and K. Sakamoto, "Mouse 3T3-L1 cells acquire resistance against oxidative stress as the adipocytes differentiate via the transcription factor FoxO," Apoptosis, vol. 15, no. 1, pp. 83-93, 2010.
70. H.-Y. Lee, H.-J. You, J.-Y. Won et al., "Forkhead factor, FOXO3a, induces apoptosis of endothelial cells through activation of matrix metalloproteinases," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 2, pp. 302-308, 2008.
71. P. F. Dijkers, R. H. Medema, J.-W. J. Lammers, L. Koenderman, and P. J. Coffer, "Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1," Current Biology, vol. 10, no. 19, pp. 1201-1204, 2000.
72. M. Potente, B. Fisslthaler, R. Busse, and I. Fleming, "11,12- Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1,"The Journal of Biological Chemistry, vol. 278, no. 32, pp. 29619-29625, 2003.
73. H.-S. Kim, C. Skurk, H. Maatz et al., "Akt/FOXO3a signaling modulates the endothelial stress response through regulation of heat shock protein 70 expression," The FASEB Journal, vol. 19, no. 8, pp. 1042-1044, 2005.
74. L. M. Ellerby, H. M. Ellerby, S. M. Park et al., "Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2," Journal of Neurochemistry, vol. 67, no. 3, pp. 1259-1267, 1996.
75. D. W. Voehringer and R. E. Meyn, "Redox aspects of Bcl-2 function," Antioxidants and Redox Signaling, vol. 2, no. 3, pp. 537-550, 2000.
76. A. Hochman, H. Sternin, S. Gorodin et al., "Enhanced oxidative stress and altered antioxidants in brains of Bcl-2- deficient mice," Journal ofNeurochemistry, vol. 71,no. 2, pp.741-748, 1998.